Nanocarrier-Based Targeted Therapies for Myocardial Infarction

Thomashire Anita George, Chuan-Chih Hsu, Annette Meeson, David J. Lundy

研究成果: 雜誌貢獻文章同行評審

摘要

Myocardial infarction is a major cause of morbidity and mortality worldwide. Due to poor inherent regeneration of the adult mammalian myocardium and challenges with effective drug delivery, there has been little progress in regenerative therapies. Nanocarriers, including liposomes, nanoparticles, and exosomes, offer many potential advantages for the therapy of myocardial infarction, including improved delivery, retention, and prolonged activity of therapeutics. However, there are many challenges that have prevented the widespread clinical use of these technologies. This review aims to summarize significant principles and developments in the field, with a focus on nanocarriers using ligand-based or cell mimicry-based targeting. Lastly, a discussion of limitations and potential future direction is provided.
原文英語
期刊Pharmaceutics
14
發行號5
DOIs
出版狀態已發佈 - 2022

指紋

深入研究「Nanocarrier-Based Targeted Therapies for Myocardial Infarction」主題。共同形成了獨特的指紋。

引用此